Search
Latest
- Therapeutic Potential of Melatonin Counteracting Chemotherapy-Induced Toxicity in Breast Cancer Patients: A Systematic Review
- The profile of melatonin production in tumour-bearing rats
- Preinduction Serum Vitamin D3 Levels and Induction Chemotherapy Remission Rates in Patients with Acute Leukemia
- The Effects of Melatonin Administration on Intestinal Injury Caused by Abdominal Irradiation from Mice
- Association between preoperative vitamin D level and postoperative pain in patients undergoing breast cancer surgery: a prospective observational study
- Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin
- TARGETING TUMOR ASSOCIATED MACROPHAGES (TAMS) FOR CANCER TREATMENT: EXPLOITING MELATONIN AS BIOLOGICAL RESPONSE MODIFIER (BRM)
- SSTR2-targeting therapy in EBV-positive and EBV-negative metastatic nasopharyngeal carcinoma
- PROMISING COMPOUNDS WITH HEALTH BENEFITS: PHYTOMELATONIN AND MELATONIN
- Understanding the role of melatonin in cancer metabolism
- Melatonin: an essential factor for the treatment and recovery from leukemia and cancer
- Radioprotective effects of melatonin on radiation-induced cataract
- Radiomitigation by Melatonin in C57BL/6 Mice: Possible Implications as Adjuvant in Radiotherapy and Chemotherapy
- Radiation-Induced Dual Oxidase Upregulation in Rat Heart Tissues: Protective Effect of Melatonin
- Disease Control after Androgen Deprivation Therapy Combined with Di Bella Multitherapy
- Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review
- Radioprotective effect of melatonin on radiation-induced lung injury and lipid peroxidation in rats
- Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- How effective is chemo therapy?
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Vademecum
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer




